Topic: MS

REPORT FROM AAN 2024 – TUESDAY, APRIL 16

April 16, 2024  

REPORT FROM AAN 2024 – MONDAY, APRIL 15

April 15, 2024  

Fluid biomarkers: theory and practice

March 18, 2024  

Evobrutinib in MS – ACTRIMS Forum update

March 11, 2024  

New consensus statement on MRI biomarkers in MS

February 20, 2024  

No benefit with adjuvant vitamin D in MS: meta-analysis

February 12, 2024  

McDonald criteria 2024: what changes can we expect?

January 30, 2024  

First-line anti-CD20 therapy – the new standard of care in MS?

January 25, 2024  

MS Awards 2023 – Oddities and observations

December 19, 2023  

The year in review – 2023

December 12, 2023